Carvalho · Sports medicine (Auckland, N.Z.) 2022 · systematic review and meta-analysis · n=60 studies

Can I Have My Coffee and Drink It? A Systematic Review and Meta-analysis to Determine Whether Habitual Caffeine Consumption Affects the Ergogenic Effect of Caffeine.

Cited 48 times in the scientific literature.

Level 1 - systematic review of randomized trials

Systematic review and meta-analysis of randomized/controlled caffeine supplementation trials

PubMed 35536449 · doi:10.1007/s40279-022-01685-0 · record verified 2026-08-29

What was done

Authors conducted a systematic review and three-level meta-analysis of 60 studies to evaluate whether habitual caffeine intake modifies the acute ergogenic effect of caffeine supplementation. Analyses assessed overall performance outcomes and sub-analyses based on exercise modality (endurance, power, strength), sex, training status, acute relative dose (<3, 3–6, >6 mg/kg body mass), dose relative to habitual intake (higher vs. lower), and withdrawal periods (<24, 24–48, >48 h).

What was found

Caffeine significantly improved exercise performance compared to placebo overall (standardized mean difference [SMD] = 0.25, 95% CI 0.20–0.30; p < 0.001), with no modifying effect of relative habitual caffeine consumption (p = 0.59). Ergogenic effects remained significant for acute doses <3 mg/kg (SMD = 0.26, 95% CI 0.12–0.40; p = 0.003) and 3–6 mg/kg (SMD = 0.26, 95% CI 0.21–0.32; p < 0.0001), but not >6 mg/kg (SMD = 0.11, 95% CI -0.07 to 0.30; p = 0.23). Performance improved whether the acute dose was higher (SMD = 0.26, 95% CI 0.20–0.31; p < 0.001) or lower (SMD = 0.21, 95% CI 0.06–0.36; p = 0.006) than habitual daily intake, and across all withdrawal windows. Habitual intake did not influence results across exercise types (all p ≥ 0.23), sex, or training level.

Why it matters

Habitual caffeine consumers maintain acute performance enhancements from caffeine supplementation, suggesting that pre-competition caffeine withdrawal or washouts are unnecessary to derive ergogenic benefits.

Limits

The abstract does not state the total number of individual participants across the 60 studies. Sub-analysis of doses >6 mg/kg was non-significant, potentially due to fewer studies at high doses. The findings are bounded by the reporting quality and methods of habitual caffeine intake estimation used in the underlying trials.

Cited by